Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux - The 'sensitive oesophagus'

Gut

Volumn 40, Issue 5, 1997, Pages 587-590

  Watson, R G P ^a   Tham, T C K ^a   Johnston, B T ^a   McDougall, N I ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

GORD; Oesophageal sensitivity; Omeprazole; Physiological reflux; Symptom index

Indexed keywords

ANTACID AGENT; OMEPRAZOLE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STOMACH ACID; SYMPTOMATOLOGY;

EID: 0030947488     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.40.5.587     Document Type: Article

References (26)

1. Behar J, Biancani P, Sheahan DG. Evaluation of esophageal tests in the diagnosis of reflux esophagitis. Gastroenterology 1976; 71: 9-15.
2. Johansson K-E, Ask P, Boeryd B, Fransson S-G, Tibbling L. Ocsophagitis, signs of reflux and gastric secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol 1986; 21: 837-47.
3. Knill-Jones RP, Card WI, Crean GP, James WB, Spiegelhalter DJ. The symptoms of gastro-oesophageal reflux and of oesophagitis. Scand J Gastroenterol 1984; 19 (suppl 106): 72-6.
4. Little AG, De Meester TR, Kirchner PT, O'Sullivan GC, Skinner DB. Pathogenesis of oesophagitis in patients with gastroesophageal reflux. Surgery 1980; 88: 101-7.
5. McDougall NI, Dickey W, Johnston BT, Collins JSA, Love AHG. An audit of the role of ambulatory oesophageal pH monitoring in clinical practice. Eur J Gastroenterol Hepatol 1994; 6: 523-7.
6. Johnston BT, McFarland RJ, Collins JSA, Love AHG. Are esophageal symptoms reflux related? A study of different scoring systems in a cohort of patients with heartburn. Am J Gastroenterol 1994; 89: 497-502.
7. Eriksen CA, Cullen PT, Sutton D, Kennedy N, Cuschieri A. Abnormal esophageal transit in patients with typical reflux symptoms but normal endoscopic and pH profiles. Am J Surg 1991; 161: 657-61.
8. Johnston BT, McFarland RJ, Collins JSA, Love AHG. The symptom index: a useful marker of gastro-oesophageal reflux disease. Br J Surg 1992; 79: 1054-5.
9. Singh S, Richter JE, Bradley LA, Haile JM. The symptom index: differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci 1993; 38: 1402-8.
10. Trimble KC, Pryde A, Heading RC. Lowered oesophageal sensory thresholds in patients with symptomatic hut not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut 1995; 37: 7-12.
11. Shi G, Bruley Des Varannes S, Scarpignato C, Le Rhun M, Galmiche J-P. Reflux related symptoms in patients with normal oeosphageal exposure to acid. Gut 1995; 37: 457-64.
12. Jenkinson C, Coulter A, Wright L. Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ 1993; 306: 1437-40.
13. Brazier JE, Harper R, Jones NMB, O'Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992; 305: 160-4.
14. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use in the XHS? BMJ 1995; 306: 1440-4.
15. McDougall NI, Johnston BT, Kee F, Collins JSA, McFarland RJ, Watson RGP, Love AHG. The effect of healing of oesophagitis on patient quality of life. Gut 1994; 35 (suppl 5): S13.
16. Wiener GJ, Morgan TM, Copper PA, Wu WC, Castell DO, Sinclair JW, Richter JE. Ambulatory 24-hour esophageal pH monitoring: reproducibility and variability of pH parameters. Dig Dis Sci 1988; 33: 1127-33.
17. Staun M, Rune SJ. Controlled single subject trial to identify patients with acid related dyspepsia. Scand J Gastroenterol 1992; 27 (suppl 190): 34.
18. Richter JE, Schan C, Burgard S, Bradley L. Placebo controlled trial of omeprazole in the treatment of acid-related non-cardiac chest pain (NCCP). Am J Gastroenterol 1992; 87: 1255.
19. Young MK, Sanowski KA, Talbert GA, Harrison ME, Walker BE. Omeprazole administration as a test for gastroesophageal reflux [abstract]. Gastroenterology 1992; 102: A192.
20. Zierer ST, Sanowski RA, Young MF, Squillance SJ. Can a single dose of omeprazole be used to identify gastroesophageal reflux and acid-related chest pain? Am J Gastroenterol 1993; 88: 1501.
21. Johannessen T, Fjøsne U, Kleveland PM, Halvorsen T, Kristensen P, Løge I, et al. Cimetidine responders in non-ulcer dyspepsia. Scand J Gastroenterol 1988; 23: 327-36.
22. Johannessen T. Controlled trials in single subjects. I. Value in clinical medicine. BMJ 1991; 303: 173-4.
23. Lewis JA. Controlled trials in single subjects. II. Limitations of use. BMJ 1991; 303: 175-6.
24. Trimble KC, Douglas S, Pryde A, Heading RC. Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux. Dig Dis Sci 1995; 40: 1098-104.
25. Trimble KC, Farouk R, Pryde A, Douglas S, Heading RC. Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalised disorder of gut sensitivity. Dig Dis Sci 1995; 40: 1607-13.
26. Marrero JM, de Caestecker JS, Maxwell JD. Effect of famotidine on oesophageal sensitivity in gastrooesophageal reflux disease. Gut 1994; 35: 447-50.